PBM
Psyence Biomedical Ltd. Common Shares
Mentions (24Hr)
50.00% Today
Reddit Posts
Mentions
Im not exactly sure what its called or how exactly it works but stocks can only go up a certain amount overnight before whats essentially a halt. CMND and PBM are both there.
PBM , TOVX this week is gonna start with fireworks.
Shoulda held PBM over the weekend instead of taking a loss. That shit's gonna go crazy in Pre it's already up lol. CTNT as well. Good luck everyone. I know I need it.
DFTX the stable one, PBM higher beta
For what its worth the only stock that actually ran without dumping so far off this is PBM.
How do we feel about PBM on Monday? Like would it be worth to buy in Sunday night if it stays above $6? We saw what? $13 on Friday? I mean the news is already broken so I'm sure we will see either a run or a new resistance come Sunday night. But how far can it run beyond $13?
PBM already surged you should look at CNMD for a short term pump
Ok, he did sign the EO for "Accelerating Medical treatments for Serious Illness." $PBM $CMND for Monday?
If trump doesnt sign that order this week then PBM will dump monday im sure.
PBM 
AGAE ROLR ISPC EFOI NPT MYSE AND PBM for after hours
buying a dip in PBM when it comes
If PBM why not CMND?
[Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine](https://www.globenewswire.com/news-release/2026/04/17/3276227/0/en/Psyence-BioMed-Welcomes-U-S-Executive-Action-to-Advance-Research-into-Ibogaine.html) \- PBM PBMWW deSPAC PBM up about 70% pre-market after news reports that an executive order is coming to approve further research into ibogaine. [https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/](https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/) "The White House is drafting an executive order that would signal the Trump administration's willingness to further U.S. research into a drug called ibogaine." PBM has completed cumulative reverse splits of about 1 for 3736 shares, so the warrants aren't likely to move much.
PBM news release https://www.stocktitan.net/news/PBM/psyence-bio-med-welcomes-u-s-executive-action-to-advance-research-8dicsvp8zf8s.html
MYSE ISPC PBM AGAE today
PBM 20+ today after taco announcement
PBM 20+ today after trumps announcement.
PBM 20+ today after trumps signs
PBM hopefully nother leg up.
Went into PBM in 6 and took out now in 11.5. Got into BZAI - The volume is hard to ignore
PBM $$$$$ on a crazy run already this a.m. today should be interesting
Cause people who use Charles Schwab cant even buy CMND the mc is so low. PBM is the norm choice so running hardest. Im betting PBM people take profits put it into CMND now like any meme sector.
Thanks for the link! Why is PBM running faster and higher than CMND?
PBM up big... I didn't buy it yesterday at 5,65 and now it moons...
https://www.reddit.com/r/pennystocks/s/RVX4Eoqh6p Take a look here, trump signed executive order to allow psychedelics to treat PTSD. CMND is a focus PBM blew up yesterday
$PBM - could run into double digits. Held all gains and ran big AH
$PBM - run AH and held. Do your own DD. https://www.gurufocus.com/news/8798845/psyence-biomedical-pbm-gears-up-for-increased-regulatory-scrutiny?mobile=true
Cmnd wouldn't be related to that eo, PBM is what you'd need
Better go PBM. Apparently this is specifically related to *ibogaine* and the other two companies are not doing anything with it. Psyence is very involved with ibogaine according to AI. This looks like your best bet
PBM is holding overnight ....
$PBM - President Trump at the wheel! Big runner AH! https://www.gurufocus.com/news/8798845/psyence-biomedical-pbm-gears-up-for-increased-regulatory-scrutiny?mobile=true Do your DD
$PBM https://www.gurufocus.com/news/8798845/psyence-biomedical-pbm-gears-up-for-increased-regulatory-scrutiny?mobile=true
Why PBM going up whts the news
Yo if PBM goes past $10 it’s gonna fly
Just glancing at the chart, it looks like PBM is back on a bit of a downtrend
What do you have more confidence in: PBM or CMND?
The best current reporting says the White House is **drafting** an order and that Trump **intends to sign it as soon as this week**. That is not the same as a signed, published order. On the substance question, the current reporting points to **ibogaine** as the main focus of the proposed order. ATAI is the best choice because it has **real ibogaine exposure through IBX-210** while also being a **larger, more diversified psychedelic biotech**, so you are not relying on just one speculative headline. It is a cleaner, more durable way to play ibogaine than tiny momentum names like PBM, which are more vulnerable to sharp reversals. \+ its chart looks more stable
GPRO PBM MYSE maybe AGAE
PBM is very volatile. Halted down now.
I need agae to go to $1 and PBM to go to $100!
Glanced at PBM to see how it's doing (not in) and it's at 666. Reluctance to trade it confirmed lol
not leaving PBM til i get 10$ IDC
CMND is next after PBM
in on CMND, it can be another run as PBM
PBM is running again, i told yall
PBM NEWSS [https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/](https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/) if it breaks 10 it could fly
Talked PBM $$$$$ FOR A FEW DAYS NOW. WHO JUMPED ON?!
PBM - Trump signs executive order on Psycodelic drugs. Stock Halted
PBM $$$ Will be interesting in the next few weeks!
PBM$$$$ no debt, limited shares....been watching. Been doing some crazy movement this morning....check it out
PBM stocks jump 10% after Medicare Advantage and Part D rate announcements and Oz is saying that it helps the average American afford healthcare? lmfao how do people believe these clowns
These companies have been ripping off Americans for years. They sell the same drugs much cheaper overseas. Whether it’s tariffs or MFN, we need strong action to stop Big Pharma and their PBM friends from overcharging us. Patients first, not pharma profits.
PBM$$$$$$ soon huge jump..waiting for the news. Bright minds 2.0
Europe negotiates the lower cost and Pharma knows this and charges the US more for the same product The insurance companies in the US have consolidated insurance, PBM, and Pharmacy into one entity. Effectively screwing the consumer at every step. Two things can be true at one time. If Europeans paid their fair share fir drug development and cost the US consumers would pay less. However, Europeans would lose gold level welfare state designation as their entitlement programs collapsed. This is why I have no issue with Most-Favored-Nation designation for drugs. The US does not normally negotiate drug cost.
PBM$$$$ another Bright minds coming up!
If this is a turnaround, the key variables are retention, PBM/partner economics, and whether cash flow can stay durable without heavy marketing spend. No position—interesting setup, but I’d want a cleaner view on sustainable margin improvement.
PBM is is starting to ramp up watching...
MGRX news was Friday it ran slightly compared to its upside range ...should be good for 1.00 to 1.20 if it charts good in the am.. SGN news was big and they also have range to over 1.00+.. PBM merger news was late Friday so didnt have the chance to get the volume really going and it has large upside potential.. All have to prove themselves on the charts tomorrow no trade if the setup doesnt work out ....
Watching SGN ,MGRX and PBM..
PBM running little bit due news.
The all-time high closing price for [Psyence Biomedical (PBM)](https://www.google.com/search?client=firefox-b-1-d&q=Psyence+Biomedical+%28PBM%29&mstk=AUtExfAqLGdZR-gMnaO1deDUdpmsi5YuIQAGKrDmYuCjw6P2YYTFL0zdQ0QCkGLxcas0gYV2uWq7t3VVDkwEEV6XZpRbT_hzkZ7k3VMhsmWS7gdo-WsqhJJWRoCt2k9XbisfxTPMPxRIL7hG2484Sf1n1LUz9_mJyv8FmFLneL8Ciqrb7PI&csui=3&ved=2ahUKEwimrtC_vdeSAxVMG9AFHUSkJlwQgK4QegQIARAB) was $268,359.00 on November 21, 2023 (adjusted to pre-splits share price obviously) Today's closing price - $3.09 Ouch!!!
You mean the PBM. Pharmacy and insurance don't interact.
Hopefully nobody missed $PBM. Put it out there earlier. It just might not be done yet.
Keep an eye on PBM. Keeps getting halted but worth a peep 👀
PBM another one of these run, halt, run halt that is impossible to get into
Their visor tech was used in the Venezuela raid. They're partly embedded in the US military which is why Congress won't target them as a monopoly. Microsoft and Nvidia are safe from antitrust regulation, because our leaders are afraid that splitting them up or hindering them in any meaningful way will allow China to leap ahead of us technologically, with their own corporations. The only "monopoly" we've split in years was CVS and Aetna. But Id argue they weren't really a monopoly to begin with: buying Aetna, the largest PBM, was just a strategy to shield them from Walmart and Amazon's expansion into pharmaceuticals. They also paid too much for the PBM and have been reeling from the cost
They have been ripping off people in health plans and employer groups for years and closing independent pharmacies with their underwater payments for services rendered for their PBM . They are about to have that rug yanked , you will see more insiders from the government dumping this trash companies stock.
In the case of UNH, your comment is not accurate at all. Over the past decade or so they have been aggressively both vertically and horizontally integrating to keep all the money for themselves. Even Congress has called them out for it, specifically buying out other insurance companies and expanding into the PBM business yet their prices have only increased.
True, but Buffet usually bets on durability over decades, not smooth quarters and PBM reform is a real earnings headwind in the sort to medium term.
Oh, health dropped due to PBM investigation for CVS and UNH(they own optumrx)
$PBM cancelled RS announcement today. $PFSA has a RS proposal on the vote for 1/27. Maybe some of these - low float stocks sorted by lowest RSI ;) https://preview.redd.it/u68jnhvyzreg1.png?width=1743&format=png&auto=webp&s=2436535e2d8e01b06e38acb199a4dbf760c36005
ACRV was a PBM level bull trap
I have completed a structural and probabilistic audit of Geron Corporation (GERN). I’M GOING ALL IN AND STARTING A SQUEEZE. The entity has transitioned from a clinical-stage narrative to a commercial execution engine following the FDA approval of Rytelo (imetelstat) in mid-2024. Phase 1: The Archetype • ECONOMIC DNA: DISRUPTOR (Commercial-Stage). Geron is moving from a "Capital Sink" to a "Revenue Engine." The core driver is Imetelstat’s first-in-class telomerase inhibitor status for Low-Risk MDS. • VALUATION BRIDGE: Market sentiment is currently depressed (trailing ~12% decline month-over-month) due to a Q3 2025 revenue miss ($47.2M vs $54M expected). The Valuation Delta is wide: the market is pricing in a "linear growth" failure, while structural reality shows a 150-account expansion (1,150 total) and a 97% gross margin. • CAPITAL VELOCITY: Currently a reinvestor. The entity is aggressively burning cash for the EU launch (2026) and the IMpactMF Phase 3 trial. Phase 2: Stability Scan • PRICING RESILIENCE: PRICE MAKER. In the orphan/specialty heme-onc space, Rytelo holds significant pricing power, though it faces competition from Bristol Myers Squibb’s Reblozyl. • CAPITAL STRUCTURE AUDIT: LEAN/STABLE. Cash and equivalents sit at $420M (as of Sept 30, 2025). With a revised downward OpEx guidance ($250M-$260M), the runway extends into 2026/27, reducing immediate dilution risk. • SYSTEMIC RISK: High sensitivity to Medicare/PBM drug pricing negotiations and the "adoption lag" in community oncology centers. Phase 3: Analytic Deep-Dive • MARKET PLUMBING: • Implied Volatility (IV): 76.0 (63rd percentile). Options are pricing in higher-than-average movement. • Put-Call Ratio (PCR): 0.06. Extreme bullish skew in open interest; the market is heavily bet on a "call-side" recovery. • Gamma Walls: High concentration at the $2.00 and $3.00 strikes. Price is currently pinned in a "liquidity vacuum" below $1.50, lacking the delta-buying pressure to trigger a squeeze. • SIGNAL AUDIT: Smart money remains anchored. RA Capital and BlackRock hold significant positions (>16% combined). Recent 1/3 workforce reduction (Dec 2025) suggests a pivot toward "Efficiency over Expansion." • TIMESTAMP: Data retrieved as of Dec 30, 2025, 21:28 EST. Phase 4: Probabilistic Synthesis (Bayesian Update) • THE PRIOR: Biotech commercial transitions succeed in scaling to profitability only ~15% of the time within 24 months. • THE UPDATES: • Tier A (1.0): FDA/EMA Approval secured; Rytelo 97% gross margins (High Quality). • Tier B (0.6): Q3 2025 revenue miss; demand down 3% QoQ; workforce reduction (Mixed Quality). • Tier C (0.3): Bullish analyst price targets ($3.00+); high short interest ratio (10+ days to cover). • THE POSTERIOR: Calculated probability of outperforming the XBI (Biotech Index) over 18 months: 58%. The workforce reduction and EU launch prep act as the primary "Update" to the success probability. Final Synthesis & Output Confluence/Divergence: DIVERGENCE. The Chart/Price Action is bearish (near 52-week lows), but the Options Chain (PCR 0.06) and Institutional Holding (RA Capital) are aggressively bullish. This signals a "Value Trap" for short-term traders but a "Generational Entry" for long-term Bayesian players. 3. CONVICTION SCORE: TIER 2 (Strategic Opportunity) • The "Product" works and the "Moat" is legal/regulatory. The "Risk" is purely execution-speed. 4. DATA INTEGRITY SCORE: 9/10 • Recent Q3 filings and Dec 2025 restructuring news provide high-freshness data.
Haven’t seen too much about PBM on Reddit, maybe I need to dig deeper. Any of you all have thoughts about what happened on Friday, was it quad witching? Fin-tel shows 2.5M dark pool shorts applied on Friday and they went from good news, $2.06/share down to under a dollar. I jumped in around the dollar mark with a few thousand shares, I’ve swung this a few times this year, but trying to figure out are we going to probably be held down for a longer time period, or are we going to probably bust from a squeeze with their next exciting update? Seems like someone is trying to kill this stock and company…
ASTI…what a recovery bought at 2.39, hit a 52 week low twice lol then hit a 52 week high 3 weeks later…did it again on PBM, and again on CMBM. I don’t like talking about it lol
Can PBM capture the same lightning as Bright minds? Buying some shares gonna test it out...its gotta pop right?
PBM has some potential also.
In terms of plan providers, I know a lot of people talk about UNH, MOH, CNC, ELV but Cigna seems like a name never talked about. They have little to no medicare or medicaid exposure (which I would prefer to avoid) as they primarily serve employer plans. The one caveat is they are a large PBM, so not really a loved industry at the moment. They took a large haircut this past earnings due to expected margin pressures as they are revamping the PBM business from rebate to fixed rate to align with political pressures. Not an exciting name to be honest, but a bit low beta if you are looking for that. Trades very cheap (forward P/E of 8) as the margin pressures are fairly well discounted now. Management did state they except modest growth despite these headwinds. CEO bought a large number of shares on the sell-off post earnings (near the 240 level).
Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies
PBM - holy cow! The news this morning was a nothingburger, but I'm not seeing why it resulted in a 22% drop to below its 52-week low.
PBM working on a rebound